180 related articles for article (PubMed ID: 7942840)
21. Carrier screening for cystic fibrosis: a perinatal perspective.
Demsey SA
J Perinat Neonatal Nurs; 1999 Sep; 13(2):14-26. PubMed ID: 10818851
[TBL] [Abstract][Full Text] [Related]
22. PCR-based screening for cystic fibrosis carrier mutations in an ethnically diverse pregnant population.
Grody WW; Dunkel-Schetter C; Tatsugawa ZH; Fox MA; Fang CY; Cantor RM; Novak JM; Bass HN; Crandall BF
Am J Hum Genet; 1997 Apr; 60(4):935-47. PubMed ID: 9106541
[TBL] [Abstract][Full Text] [Related]
23. Acceptance of home and clinic-based cystic fibrosis carrier education and testing by first, second, and third degree relatives of cystic fibrosis patients.
Sorenson JR; Cheuvront B; DeVellis B; Callanan N; Silverman L; Koch G; Sharp T; Fernald G
Am J Med Genet; 1997 May; 70(2):121-9. PubMed ID: 9128929
[TBL] [Abstract][Full Text] [Related]
24. An interactive computer program can effectively educate potential users of cystic fibrosis carrier tests.
Castellani C; Perobelli S; Bianchi V; Seia M; Melotti P; Zanolla L; Assael BM; Lalatta F
Am J Med Genet A; 2011 Apr; 155A(4):778-85. PubMed ID: 21416590
[TBL] [Abstract][Full Text] [Related]
25. Cystic fibrosis testing 8 years on: lessons learned from carrier screening and sequencing analysis.
Strom CM; Crossley B; Buller-Buerkle A; Jarvis M; Quan F; Peng M; Muralidharan K; Pratt V; Redman JB; Sun W
Genet Med; 2011 Feb; 13(2):166-72. PubMed ID: 21068670
[TBL] [Abstract][Full Text] [Related]
26. Highlighting the impact of cascade carrier testing in cystic fibrosis families.
Duguépéroux I; L'Hostis C; Audrézet MP; Rault G; Frachon I; Bernard R; Parent P; Blayau M; Schmitt S; Génin E; Férec C; Scotet V
J Cyst Fibros; 2016 Jul; 15(4):452-9. PubMed ID: 27013383
[TBL] [Abstract][Full Text] [Related]
27. Genetic testing for cystic fibrosis. National Institutes of Health Consensus Development Conference Statement on genetic testing for cystic fibrosis.
Arch Intern Med; 1999 Jul; 159(14):1529-39. PubMed ID: 10421275
[TBL] [Abstract][Full Text] [Related]
28. Population-based newborn screening for genetic disorders when multiple mutation DNA testing is incorporated: a cystic fibrosis newborn screening model demonstrating increased sensitivity but more carrier detections.
Comeau AM; Parad RB; Dorkin HL; Dovey M; Gerstle R; Haver K; Lapey A; O'Sullivan BP; Waltz DA; Zwerdling RG; Eaton RB
Pediatrics; 2004 Jun; 113(6):1573-81. PubMed ID: 15173476
[TBL] [Abstract][Full Text] [Related]
29. Teaching about cystic fibrosis carrier screening by using written and video information.
Clayton EW; Hannig VL; Pfotenhauer JP; Parker RA; Campbell PW; Phillips JA
Am J Hum Genet; 1995 Jul; 57(1):171-81. PubMed ID: 7611285
[TBL] [Abstract][Full Text] [Related]
30. Communication of carrier status information following universal newborn screening for sickle cell disorders and cystic fibrosis: qualitative study of experience and practice.
Kai J; Ulph F; Cullinan T; Qureshi N
Health Technol Assess; 2009 Nov; 13(57):1-82, iii. PubMed ID: 19948087
[TBL] [Abstract][Full Text] [Related]
31. Ethical considerations in choosing a model for population-based cystic fibrosis carrier screening.
Modra LJ; Massie RJ; Delatycki MB
Med J Aust; 2010 Aug; 193(3):157-60. PubMed ID: 20678044
[TBL] [Abstract][Full Text] [Related]
32. Pediatric and Adult Recommendations Vary for Sibling Testing in Cystic Fibrosis.
Brown KL; Flume PA
J Genet Couns; 2018 Sep; 27(5):1049-1054. PubMed ID: 29429040
[TBL] [Abstract][Full Text] [Related]
33. Preconceptional cystic fibrosis carrier screening: opinions of general practitioners, gynecologists, and pediatricians in the Netherlands.
Baars MJ; Henneman L; ten Kate LP
Genet Test; 2004; 8(4):431-6. PubMed ID: 15684876
[TBL] [Abstract][Full Text] [Related]
34. Attitudes of potential providers towards preconceptional cystic fibrosis carrier screening.
Poppelaars FA; Adèr HJ; Cornel MC; Henneman L; Hermens RP; van der Wal G; ten Kate LP
J Genet Couns; 2004 Feb; 13(1):31-44. PubMed ID: 19739281
[TBL] [Abstract][Full Text] [Related]
35. Cystic fibrosis newborn screening: a pilot study to maximize carrier screening.
Lagoe E; Labella S; Arnold G; Rowley PT
Genet Test; 2005; 9(3):255-60. PubMed ID: 16225405
[TBL] [Abstract][Full Text] [Related]
36. Screening for carriers of cystic fibrosis among pregnant women: a pilot study.
Schwartz M; Brandt NJ; Skovby F
Eur J Hum Genet; 1993; 1(3):239-44. PubMed ID: 8044649
[TBL] [Abstract][Full Text] [Related]
37. Mixed messages: presentation of information in cystic fibrosis-screening pamphlets.
Loeben GL; Marteau TM; Wilfond BS
Am J Hum Genet; 1998 Oct; 63(4):1181-9. PubMed ID: 9758594
[TBL] [Abstract][Full Text] [Related]
38. Cystic fibrosis gene analysis: recent diagnostic applications.
Fujimura FK
Clin Biochem; 1991 Aug; 24(4):353-61. PubMed ID: 1959227
[TBL] [Abstract][Full Text] [Related]
39. Prenatal cystic fibrosis carrier testing: designing an information leaflet to meet the specific needs of the target population.
Mennie ME; Liston WA; Brock DJ
J Med Genet; 1992 May; 29(5):308-12. PubMed ID: 1583657
[TBL] [Abstract][Full Text] [Related]
40. [Cystic fibrosis carrier screening: a Health technology assessment.].
Colombo C; Banzi R; Gerardi C; Allocati E; Mosconi P; Foglia E; Ferrario L; Romano F; Castellani C;
Recenti Prog Med; 2024 Jan; 115(1):35-39. PubMed ID: 38169359
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
